XML 61 R40.htm IDEA: XBRL DOCUMENT
v3.24.0.1

Share-Based Compensation (Tables) | 12 Months Ended
--- | ---
Dec. 31, 2023
Share-Based Payment Arrangement [Abstract] |
Summary of Share-Based Compensation (income) expense | The following table summarizes share-based compensation expense:
|  | Year Ended December 31, |
(in thousands) |  | 2023 |  |  | 2022 |  |  | 2021 |
Performance-based restricted stock units |  | $ | 3,282 |  |  | $ | 541 |  |  | $ | 549 |
Restricted stock awards and restricted stock units |  |  | 6,523 |  |  |  | 6,703 |  |  |  | 5,451 |
Stock options |  |  | 1,647 |  |  |  | 2,997 |  |  |  | 1,727 |
Share-based compensation expense before income tax |  |  | 11,452 |  |  |  | 10,241 |  |  |  | 7,727 |
Income tax benefit(1) |  |  | (151 | ) |  |  | (117 | ) |  |  | (82 | )
Share-based compensation expense, net of income tax |  | $ | 11,301 |  |  | $ | 10,124 |  |  | $ | 7,645 |
(1) The income tax benefit amount for all periods primarily reflects the tax benefit associated with our Canadian-based employees. Refer to Note 18 – Income Taxes.
Summary of Activity of the Outstanding PUP Awards | The following table summarizes the activity of the outstanding PRSU awards:
|  | Equity-Based PRSUs |  |  | Liability-Based PRSUs |
|  | Shares |  |  | Weighted-Average Grant Date Fair Value |  |  | Shares |  |  | Weighted-Average Grant Date Fair Value |
Balance at December 31, 2022 |  |  | 101,785 |  |  | $ | 31.28 |  |  |  | 40,075 |  |  | $ | 56.06 |
Granted(1) |  |  | 191,883 |  |  | $ | 36.48 |  |  |  | — |  |  | $ | — |
Vested |  |  | — |  |  | $ | — |  |  |  | (40,075 | ) |  | $ | 56.06 |
Forfeited(1) |  |  | (9,475 | ) |  | $ | 36.46 |  |  |  | — |  |  | $ | — |
Balance at December 31, 2023 |  |  | 284,193 |  |  | $ | 34.62 |  |  |  | — |  |  | $ | — |
(1) Includes adjustments for estimated achievement of performance-based criteria.
Summary of Activity of the Outstanding Restricted Stock Awards And Restricted Stock Units | The following table summarizes the activity of the outstanding restricted stock awards and restricted stock units:
|  | Equity-Based Restricted Stock Awards |  |  | Equity-Based Restricted Stock Units |  |  | Liability-Based Restricted Stock Units |
|  | Shares |  |  | Weighted-Average Grant Date Fair Value |  |  | Shares |  |  | Weighted-Average Grant Date Fair Value |  |  | Shares |  |  | Weighted-Average Grant Date Fair Value |
Balance at December 31, 2022 |  |  | 23,292 |  |  | $ | 54.03 |  |  |  | 412,019 |  |  | $ | 33.43 |  |  |  | 2,260 |  |  | $ | 54.75 |
Granted |  |  | — |  |  | $ | — |  |  |  | 227,891 |  |  | $ | 28.96 |  |  |  | — |  |  | $ | — |
Vested |  |  | (23,011 | ) |  | $ | 54.20 |  |  |  | (160,578 | ) |  | $ | 33.49 |  |  |  | (2,260 | ) |  | $ | 54.75 |
Forfeited |  |  | (11 | ) |  | $ | 56.23 |  |  |  | (30,339 | ) |  | $ | 32.92 |  |  |  | — |  |  | $ | — |
Balance at December 31, 2023 |  |  | 270 |  |  | $ | 39.28 |  |  |  | 448,993 |  |  | $ | 31.18 |  |  |  | — |  |  | $ | — |
Summary of Options Outstanding and Exercisable | The following table summarizes stock options outstanding and exercisable as of December 31, 2023:
|  | Options Outstanding |  |  | Options Exercisable |
Range of exercise prices |  | Shares |  |  | Weighted-Average Remaining Contractual Life (in years) |  |  | Weighted-Average Exercise Price |  |  | Shares |  |  | Weighted-Average Exercise Price |
$21.85 |  |  | 54,150 |  |  |  | 3.65 |  |  | $ | 21.85 |  |  |  | 54,150 |  |  | $ | 21.85 |
$33.96 |  |  | 233,970 |  |  |  | 5.15 |  |  | $ | 33.96 |  |  |  | 77,991 |  |  | $ | 33.96 |
$44.80 |  |  | 137,858 |  |  |  | 4.15 |  |  | $ | 44.80 |  |  |  | 91,906 |  |  | $ | 44.80 |
$21.85 - $44.80 |  |  | 425,978 |  |  |  | 4.64 |  |  | $ | 35.93 |  |  |  | 224,047 |  |  | $ | 35.48 |
The aggregate intrinsic value of stock options outstanding at December 31, 2023 was $1.3 million, which represents the difference between our closing stock price at the end of the reporting period and the exercise price, multiplied by the number of in-the-money stock options. The aggregate intrinsic value of options exercisable at December 31, 2023 was $1.0 million

X
- References No definition available. + Details
Name: | us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of cost recognized for award under share-based payment arrangement by plan. Includes, but is not limited to, related tax benefit. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (h)(1) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2 + Details
Name: | us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of option exercise prices, by grouped ranges, including the upper and lower limits of the price range, the number of shares under option, weighted average exercise price and remaining contractual option terms. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 2 -Publisher FASB -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2 + Details
Name: | us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Disclosure of the number and weighted-average grant date fair value for restricted stock and restricted stock units that were outstanding at the beginning and end of the year, and the number of restricted stock and restricted stock units that were granted, vested, or forfeited during the year. + References No definition available. + Details
Name: | us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of the number and weighted-average grant date fair value for outstanding performance shares. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Section 50 -Subparagraph (c) -Paragraph 2 -SubTopic 10 -Topic 718 -Publisher FASB -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2 + Details
Name: | us-gaap_ShareBasedCompensationPerformanceSharesAwardOutstandingActivityTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration